PortalPublikationenWorldwide Network for Blood and Marrow Transplantation (WBMT...

Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program

Standard

Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program. / El Fakih, Riad; Greinix, Hildegard; Koh, Mickey; Shaw, Bronwen; Mohty, Mohamad; Al Nahedh, Mohammad; Saber, Wael; Kharfan-Dabaja, Mohamed A; Perales, Miguel-Angel; Savani, Bipin N; Majhail, Navneet S; Passweg, Jakob R; Sureda, Anna; Ahmed, Syed Osman; Gluckman, Eliane; Riches, Marcie; El-Jawahri, Areej; Rondelli, Damiano; Srivastava, Alok; Faulkner, Lawrence; Atsuta, Yoshiko; Ballen, Karen K; Rasheed, Walid; Okamoto, Shinichiro; Seber, Adriana; Chao, Nelson; Kröger, Nicolaus; Kodera, Yoshihisa; Szer, Jeff; Hashmi, Shahrukh K; Horowitz, Mary M; Weisdorf, Daniel; Niederwieser, Dietger; Aljurf, Mahmoud.

in: TRANSPL CELL THER, Jahrgang 27, Nr. 3, 03.2021, S. 267.e1-267.e5.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

El Fakih, R, Greinix, H, Koh, M, Shaw, B, Mohty, M, Al Nahedh, M, Saber, W, Kharfan-Dabaja, MA, Perales, M-A, Savani, BN, Majhail, NS, Passweg, JR, Sureda, A, Ahmed, SO, Gluckman, E, Riches, M, El-Jawahri, A, Rondelli, D, Srivastava, A, Faulkner, L, Atsuta, Y, Ballen, KK, Rasheed, W, Okamoto, S, Seber, A, Chao, N, Kröger, N, Kodera, Y, Szer, J, Hashmi, SK, Horowitz, MM, Weisdorf, D, Niederwieser, D & Aljurf, M 2021, 'Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program', TRANSPL CELL THER, Jg. 27, Nr. 3, S. 267.e1-267.e5. https://doi.org/10.1016/j.jtct.2020.12.015

APA

El Fakih, R., Greinix, H., Koh, M., Shaw, B., Mohty, M., Al Nahedh, M., Saber, W., Kharfan-Dabaja, M. A., Perales, M-A., Savani, B. N., Majhail, N. S., Passweg, J. R., Sureda, A., Ahmed, S. O., Gluckman, E., Riches, M., El-Jawahri, A., Rondelli, D., Srivastava, A., ... Aljurf, M. (2021). Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program. TRANSPL CELL THER, 27(3), 267.e1-267.e5. https://doi.org/10.1016/j.jtct.2020.12.015

Vancouver

El Fakih R, Greinix H, Koh M, Shaw B, Mohty M, Al Nahedh M et al. Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program. TRANSPL CELL THER. 2021 Mär;27(3):267.e1-267.e5. https://doi.org/10.1016/j.jtct.2020.12.015

Bibtex

@article{0f31193ac0404dbf8805ce44db083aa7,
title = "Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program",
abstract = "Establishing a hematopoietic cell transplantation (HCT) program is complex. Planning is essential while establishing such a program to overcome the expected challenges. Authorities involved in HCT program establishment will need to coordinate the efforts between the different departments required to start up the program. One essential department is pharmacy and the medications required. To help facilitate this, the Worldwide Network for Blood and Marrow Transplantation organized a structured survey to address the essential medications required to start up an HCT program. A group of senior physicians and pharmacists prepared a list of the medications used at the different phases of transplantation. These drugs were then rated by a questionnaire using a scale of necessity based on the stage of development of the transplant program. The questionnaire was sent to 30 physicians, in different parts of the world, who have between 5 and 40 years of experience in autologous and/or allogeneic transplantation. This group of experts scored each medication on a 7-point scale, ranging from an absolute requirement (score of 1) to not required (score of 7). The results are presented here to help guide the prioritization of required medications.",
keywords = "Bone Marrow, Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation, Transplantation, Homologous",
author = "{El Fakih}, Riad and Hildegard Greinix and Mickey Koh and Bronwen Shaw and Mohamad Mohty and {Al Nahedh}, Mohammad and Wael Saber and Kharfan-Dabaja, {Mohamed A} and Miguel-Angel Perales and Savani, {Bipin N} and Majhail, {Navneet S} and Passweg, {Jakob R} and Anna Sureda and Ahmed, {Syed Osman} and Eliane Gluckman and Marcie Riches and Areej El-Jawahri and Damiano Rondelli and Alok Srivastava and Lawrence Faulkner and Yoshiko Atsuta and Ballen, {Karen K} and Walid Rasheed and Shinichiro Okamoto and Adriana Seber and Nelson Chao and Nicolaus Kr{\"o}ger and Yoshihisa Kodera and Jeff Szer and Hashmi, {Shahrukh K} and Horowitz, {Mary M} and Daniel Weisdorf and Dietger Niederwieser and Mahmoud Aljurf",
note = "Crown Copyright {\textcopyright} 2020. Published by Elsevier Inc. All rights reserved.",
year = "2021",
month = mar,
doi = "10.1016/j.jtct.2020.12.015",
language = "English",
volume = "27",
pages = "267.e1--267.e5",
journal = "TRANSPL CELL THER",
issn = "2666-6375",
publisher = "Elsevier BV",
number = "3",

}

RIS

TY - JOUR

T1 - Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program

AU - El Fakih, Riad

AU - Greinix, Hildegard

AU - Koh, Mickey

AU - Shaw, Bronwen

AU - Mohty, Mohamad

AU - Al Nahedh, Mohammad

AU - Saber, Wael

AU - Kharfan-Dabaja, Mohamed A

AU - Perales, Miguel-Angel

AU - Savani, Bipin N

AU - Majhail, Navneet S

AU - Passweg, Jakob R

AU - Sureda, Anna

AU - Ahmed, Syed Osman

AU - Gluckman, Eliane

AU - Riches, Marcie

AU - El-Jawahri, Areej

AU - Rondelli, Damiano

AU - Srivastava, Alok

AU - Faulkner, Lawrence

AU - Atsuta, Yoshiko

AU - Ballen, Karen K

AU - Rasheed, Walid

AU - Okamoto, Shinichiro

AU - Seber, Adriana

AU - Chao, Nelson

AU - Kröger, Nicolaus

AU - Kodera, Yoshihisa

AU - Szer, Jeff

AU - Hashmi, Shahrukh K

AU - Horowitz, Mary M

AU - Weisdorf, Daniel

AU - Niederwieser, Dietger

AU - Aljurf, Mahmoud

N1 - Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.

PY - 2021/3

Y1 - 2021/3

N2 - Establishing a hematopoietic cell transplantation (HCT) program is complex. Planning is essential while establishing such a program to overcome the expected challenges. Authorities involved in HCT program establishment will need to coordinate the efforts between the different departments required to start up the program. One essential department is pharmacy and the medications required. To help facilitate this, the Worldwide Network for Blood and Marrow Transplantation organized a structured survey to address the essential medications required to start up an HCT program. A group of senior physicians and pharmacists prepared a list of the medications used at the different phases of transplantation. These drugs were then rated by a questionnaire using a scale of necessity based on the stage of development of the transplant program. The questionnaire was sent to 30 physicians, in different parts of the world, who have between 5 and 40 years of experience in autologous and/or allogeneic transplantation. This group of experts scored each medication on a 7-point scale, ranging from an absolute requirement (score of 1) to not required (score of 7). The results are presented here to help guide the prioritization of required medications.

AB - Establishing a hematopoietic cell transplantation (HCT) program is complex. Planning is essential while establishing such a program to overcome the expected challenges. Authorities involved in HCT program establishment will need to coordinate the efforts between the different departments required to start up the program. One essential department is pharmacy and the medications required. To help facilitate this, the Worldwide Network for Blood and Marrow Transplantation organized a structured survey to address the essential medications required to start up an HCT program. A group of senior physicians and pharmacists prepared a list of the medications used at the different phases of transplantation. These drugs were then rated by a questionnaire using a scale of necessity based on the stage of development of the transplant program. The questionnaire was sent to 30 physicians, in different parts of the world, who have between 5 and 40 years of experience in autologous and/or allogeneic transplantation. This group of experts scored each medication on a 7-point scale, ranging from an absolute requirement (score of 1) to not required (score of 7). The results are presented here to help guide the prioritization of required medications.

KW - Bone Marrow

KW - Bone Marrow Transplantation

KW - Hematopoietic Stem Cell Transplantation

KW - Transplantation, Homologous

U2 - 10.1016/j.jtct.2020.12.015

DO - 10.1016/j.jtct.2020.12.015

M3 - SCORING: Journal article

C2 - 33781535

VL - 27

SP - 267.e1-267.e5

JO - TRANSPL CELL THER

JF - TRANSPL CELL THER

SN - 2666-6375

IS - 3

ER -